Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes.
Mamotte, Cyril D.S.
Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes. [electronic resource] - European journal of internal medicine Jun 2002 - 250-255 p. digital
Publication Type: Journal Article
1879-0828
10.1016/s0953-6205(02)00030-4 doi
Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes. [electronic resource] - European journal of internal medicine Jun 2002 - 250-255 p. digital
Publication Type: Journal Article
1879-0828
10.1016/s0953-6205(02)00030-4 doi